SCM
GILD icon

Sage Capital Management’s Gilead Sciences GILD Stock Holding History

Sage Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,511
Closed -$211K – 173
2026
Q1 		$211K Buy
+1,511
New +$212K 0.1% 146
2025
Q2 		– Sell
-2,435
Closed -$273K – 161
2025
Q1 		$273K Buy
2,435
+16
+0.7% +$1.65K 0.15% 115
2024
Q4 		$223K Buy
2,419
+20
+0.8% +$1.8K 0.11% 129
2024
Q3 		$201K Buy
+2,399
New +$183K 0.1% 148

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Sage Capital Management's GILD Position: Q2 2026 in Review

Sage Capital Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 1,511 shares — an estimated $211K sold.

Sage Capital Management first reported a position in GILD in Q3 2024 and held it in 4 quarters. The position peaked at $273K in Q1 2025. 759 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sage Capital Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Sage Capital Management sold 1,511 Gilead Sciences shares in Q2 2026, an estimated $211K.
  • Sage Capital Management first reported a position in Gilead Sciences in Q3 2024 and held it in 4 quarters.
  • Sage Capital Management's Gilead Sciences position peaked at $273K in Q1 2025.
  • 759 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sage Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.